Drug Shortage Report for ACH-TADALAFIL
Report ID | 195316 |
Drug Identification Number | 02515997 |
Brand name | ACH-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2023-06-16 |
Estimated end date | |
Actual end date | 2023-09-15 |
Shortage status | Resolved |
Updated date | 2023-09-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-06-16 | English | Compare |
v2 | 2023-06-16 | French | Compare |
v3 | 2023-09-15 | English | Compare |
v4 | 2023-09-15 | French | Compare |
v5 | 2023-09-16 | English | Compare |
Showing 1 to 5 of 5